• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks

    Spectral Medical Inc Closes $10 Million Bought Deal Financing

    Vivien Diniz
    Feb. 18, 2016 08:57AM PST
    Medical Device Investing

    Spectral Medical Inc, (TSX:EDT,OTCQX:EDTXF) has closed its previously announced bought deal financing pursuant to which it sold 14,300,000 common shares of the company to a syndicate of underwriters led by Cormark Securities Inc, from the treasury of the Company at a price of $0.70 per share.

    Spectral Medical Inc, (TSX:EDT,OTCQX:EDTXF) has closed its previously announced bought deal financing pursuant to which it sold 14,300,000 common shares of the company to a syndicate of underwriters led by Cormark Securities Inc, from the treasury of the Company at a price of $0.70 per share. The Shares were offered in each of the provinces of Canada, except Québec, by way of short form prospectus. The company raised aggregate gross proceeds of $10,010,000 under the offering, which will be used for the completion of the company’s EUPHRATES clinical trial, the commercialization of the company’s PMX device and for general corporate purposes.
    According to the press release:

    Under the terms of the Offering, the Company has granted the Underwriters an option (“Over-Allotment Option“) to purchase up to an additional 2,145,000 Shares from the Company at the Offering Price, exercisable at any time up to 30 days following the closing of the Offering, for market stabilization purposes and to cover over-allotments, if any. Under the Offering, the Company has also issued to the Underwriters 858,000 broker warrants totaling 6% of the number of Shares sold pursuant to the Offering. Each broker warrant entitles the holder thereof to acquire one Share at a price equal to the Offering Price for a period of 24 months from closing of the Offering.

    Click here to view the full press release. 

    canadacormark securitiesbought deal financing
    The Conversation (0)

    Go Deeper

    AI Powered
    Hawthorn Resources

    Hawthorn Announces Closing of C$4 Million Subscription Receipt Financing

    Falcon Closes Final Tranche Of Private Placement

    Falcon Closes Final Tranche Of Private Placement

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×